What is NovoCure's investing cash flow?

NovoCure (NVCR) reported investing cash flow of $7.75M in Q1 2026.

How has NovoCure's investing cash flow changed year-over-year?

NovoCure's investing cash flow increased by 219.7% year-over-year, from -$6.47M to $7.75M.

What is the long-term trend for NovoCure's investing cash flow?

Over 4 years (2021 to 2025), NovoCure's investing cash flow has grown at a 31.8% compound annual growth rate (CAGR), from -$144.83M to $437.28M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

NovoCure NVCR Investing Cash Flow

Investing Cash Flow at other companies

Boston ScientificBSX

-$591M-18.2%

MedtronicMDT

-$917M-87.1%

Iovance Biotherapeutics, Inc.IOVA

$11.39M-28.2%

Nuvation BioNUVB

-$43.64M-181%

Vir Biotechnology, Inc.VIR

$11.84M-90.7%

Syndax PharmaceuticalsSNDX

$38.39M-59.2%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Enterprise value$1.66B-36.3%

P/S2.5×-1.8×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's investing cash flow?: NovoCure (NVCR) reported investing cash flow of $7.75M in Q1 2026.
How has NovoCure's investing cash flow changed year-over-year?: NovoCure's investing cash flow increased by 219.7% year-over-year, from -$6.47M to $7.75M.
What is the long-term trend for NovoCure's investing cash flow?: Over 4 years (2021 to 2025), NovoCure's investing cash flow has grown at a 31.8% compound annual growth rate (CAGR), from -$144.83M to $437.28M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.